Ex-vivo clinical candidate drug assay against field clinical isolated blood stages parasites of P. malariae and P. ovale using 10 compounds from MMV. Medicines for Malaria Venture (MMV), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ghana, Mali
Using single-cell RNAseq to investigate human malaria parasite transmission dynamics Medical Research Council (MRC), UK, Wellcome Trust Sanger Institute, UK, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Mara K. N. Lawniczak, Abdoulaye Djimde | Africa, Central, Africa, Eastern, Africa, Southern, Mali, United Kingdom
Understanding the biology of Plasmodium vivax and Plasmodium ovale for the development of a field-based anti-hypnozoite drug screening model (HypnoBio) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ethiopia, Mali
Developing Excellence in Leadership and Genetic Training for Malaria Elimination in Sub-Saharan Africa (DELGEME) Wellcome Trust, UK, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye Djimde | Africa, Central, Africa, Eastern, Africa, Southern, Africa, Western, Mali
Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…
WANECAM is the West African Network for Clinical Trials of Antimalarial drugs. This network is being supported by grants from the European & Developing Countries Clinical Trials Partnership (EDCTP). The WANECAM 2 project aims to accelerate the development of the Ganaplacide/lumefantrine combination for the treatment of uncomplicated malaria by conducting clinical trials in four countries…
Increasing Intermittent Preventive Treatment uptake through enhanced antenatal clinic service delivery to improve maternal and child health & assessing ANC data for routine monitoring in Mali U.S. President’s Malaria Initiative (PMI), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Kassoum Kayentao, Celia Woodfill | Mali